Aspire Biopharma Holdings, Inc. - Common Stock (ASBP)
CUSIP: 738920107
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 138,530,928
- Total 13F shares
- 2,044,304
- Share change
- +608,320
- Total reported value
- $544,743
- Price per share
- $0.27
- Number of holders
- 16
- Value change
- -$131,309
- Number of buys
- 14
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 738920107?
CUSIP 738920107 identifies ASBP - Aspire Biopharma Holdings, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 738920107:
Top shareholders of ASBP - Aspire Biopharma Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Lance Friedman |
13D/G
|
— |
4.5%
|
2,207,886
|
$1,037,706 | -$782,315 | 06 May 2025 | |
| TORONTO DOMINION BANK |
13F
|
Company |
0.37%
|
516,845
|
$349,904 | — | 31 Mar 2025 | |
| Crewe Advisors LLC |
13F
|
Company |
0.23%
|
313,427
|
$182,603 | — | 31 Mar 2025 | |
| Harraden Circle Investments, LLC |
13F
13D/G
|
Company |
0.31%
from 13D/G
|
150,000
|
$87,390 | — | 31 Mar 2025 | |
| Saba Capital Management, L.P. |
13F
|
Company |
—
class O/S missing
|
983,603
|
$71,803 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
—
class O/S missing
|
1,050,000
|
$71,085 | — | 31 Mar 2025 | |
| LINDEN ADVISORS LP |
13F
|
Company |
—
class O/S missing
|
899,999
|
$65,700 | — | 31 Mar 2025 | |
| PERISCOPE CAPITAL INC. |
13F
|
Company |
—
mixed-class rows
|
483,567
mixed-class rows
|
$63,575 | — | 31 Mar 2025 | |
| Optivise Advisory Services LLC |
13F
|
Company |
0.08%
|
106,446
|
$62,015 | — | 31 Mar 2025 | |
| Procyon Advisors, LLC |
13F
|
Company |
0.07%
|
98,500
|
$57,386 | — | 31 Mar 2025 | |
| ARISTEIA CAPITAL, L.L.C. |
13F
|
Company |
—
class O/S missing
|
681,516
|
$49,751 | — | 31 Mar 2025 | |
| Sculptor Capital LP |
13F
|
Company |
—
class O/S missing
|
2,405,000
|
$36,500 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
—
class O/S missing
|
350,000
|
$31,430 | — | 31 Mar 2025 | |
| Verition Fund Management LLC |
13F
|
Company |
—
class O/S missing
|
432,757
|
$29,298 | — | 31 Mar 2025 | |
| CLEAR STREET LLC |
13F
|
Company |
—
class O/S missing
|
331,064
|
$22,413 | — | 31 Mar 2025 | |
| Platform Technology Partners |
13F
|
Company |
0.03%
|
37,611
|
$21,912 | — | 31 Mar 2025 | |
| Taconic Capital Advisors LP |
13F
|
Company |
—
class O/S missing
|
300,000
|
$20,310 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
29,945
|
$17,458 | — | 31 Mar 2025 | |
| Alberta Investment Management Corp |
13F
|
Company |
—
class O/S missing
|
250,000
|
$16,925 | — | 31 Mar 2025 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.02%
|
27,413
|
$15,971 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
26,901
|
$15,681 | — | 31 Mar 2025 | |
| Mint Tower Capital Management B.V. |
13F
|
Company |
—
class O/S missing
|
25,000
|
$15,000 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
—
class O/S missing
|
199,999
|
$13,540 | — | 31 Mar 2025 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
195,944
|
$13,265 | — | 31 Mar 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.02%
|
21,019
|
$12,246 | — | 31 Mar 2025 | |
| Athos Capital Ltd |
13F
|
Company |
—
class O/S missing
|
21,383
|
$12,000 | — | 31 Mar 2025 | |
| Context Capital Management, LLC |
13F
|
Company |
—
class O/S missing
|
175,000
|
$11,847 | — | 31 Mar 2025 | |
| Polar Asset Management Partners Inc. |
13F
|
Company |
—
class O/S missing
|
138,536
|
$10,113 | — | 31 Mar 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.01%
|
16,694
|
$10,000 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.01%
|
16,023
|
$9,340 | — | 31 Mar 2025 | |
| LMR Partners LLP |
13F
|
Company |
—
class O/S missing
|
125,000
|
$8,463 | — | 31 Mar 2025 | |
| WHITEBOX ADVISORS LLC |
13F
|
Company |
—
class O/S missing
|
118,750
|
$8,039 | — | 31 Mar 2025 | |
| Donald G. Fell |
3/4/5
|
Director |
0.01%
|
20,000
|
$7,800 | $0 | 04 Jun 2025 | |
| Clear Street Derivatives LLC |
13F
|
Company |
—
class O/S missing
|
106,000
|
$7,176 | — | 31 Mar 2025 | |
| CAAS CAPITAL MANAGEMENT LP |
13F
|
Company |
—
class O/S missing
|
75,000
|
$5,078 | — | 31 Mar 2025 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
—
class O/S missing
|
50,000
|
$3,500 | — | 31 Mar 2025 | |
| PICTON MAHONEY ASSET MANAGEMENT |
13F
|
Company |
—
class O/S missing
|
50,000
|
$3,000 | — | 31 Mar 2025 | |
| OMERS ADMINISTRATION Corp |
13F
|
Company |
—
class O/S missing
|
25,000
|
$1,825 | — | 31 Mar 2025 | |
| FLOW TRADERS U.S. LLC |
13F
|
Company |
—
class O/S missing
|
14,191
|
$1,000 | — | 31 Mar 2025 | |
| Reyes Financial Architecture, Inc. |
13F
|
Company |
—
mixed-class rows
|
210
mixed-class rows
|
$86 | — | 31 Mar 2025 | |
| Farther Finance Advisors, LLC |
13F
|
Company |
—
mixed-class rows
|
30
mixed-class rows
|
$13 | — | 31 Mar 2025 | |
| Surendra K. Ajjarapu |
3/4/5
|
Chief Executive Officer, Director, 10%+ Owner |
—
class O/S missing
|
4,317,500
|
— | — | 18 Aug 2023 | |
| PowerUp Sponsor LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,870,000
|
— | — | 18 Aug 2023 |
Institutional Holders of Aspire Biopharma Holdings, Inc. - Common Stock (ASBP) as of Q2 2025
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.